Graphtx
Vienna, AT · Founded 2024 · 14 employees on LinkedIn · 4 known investors
GraphTx is an AI-driven platform for drug discovery that validates immunology and inflammation drug targets using live patient samples before clinical trials. The company serves pharmaceutical researchers by applying machine learning to patient immune cell data to reduce development risk and failure rates.
Investors · 4
Competitors · 2
by search overlap
Robinhood4 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Ametris4 shared keywordsAmetris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.
Companies competing with Graphtx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Graphtx do?
- GraphTx is an AI-driven platform for drug discovery that validates immunology and inflammation drug targets using live patient samples before clinical trials. The company serves pharmaceutical researchers by applying machine learning to patient immune cell data to reduce development risk and failure rates.
- Who are Graphtx's investors?
- Graphtx's investors include Daphni, SquareOne, Transpose Platform Management, Merantix Capital.
- Where is Graphtx headquartered?
- Graphtx is headquartered in Vienna, AT.